Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 19:57
Insulet Max Drawdown (5Y) : 61.31% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 61.31% |
| June 30, 2026 | 61.31% |
| May 31, 2026 | 61.31% |
| April 30, 2026 | 61.31% |
| March 31, 2026 | 61.31% |
| February 28, 2026 | 61.31% |
| January 31, 2026 | 61.31% |
| December 31, 2025 | 61.31% |
| November 30, 2025 | 61.31% |
| October 31, 2025 | 61.31% |
| September 30, 2025 | 61.31% |
| August 31, 2025 | 61.31% |
| July 31, 2025 | 61.31% |
| June 30, 2025 | 61.31% |
| May 31, 2025 | 61.31% |
| April 30, 2025 | 61.31% |
| March 31, 2025 | 61.31% |
| February 28, 2025 | 61.31% |
| January 31, 2025 | 61.31% |
| December 31, 2024 | 61.31% |
| November 30, 2024 | 61.31% |
| October 31, 2024 | 61.31% |
| September 30, 2024 | 61.31% |
| August 31, 2024 | 61.31% |
| July 31, 2024 | 61.31% |
| Date | Value |
|---|---|
| June 30, 2024 | 61.31% |
| May 31, 2024 | 61.31% |
| April 30, 2024 | 61.31% |
| March 31, 2024 | 61.31% |
| February 29, 2024 | 61.31% |
| January 31, 2024 | 61.31% |
| December 31, 2023 | 61.31% |
| November 30, 2023 | 61.31% |
| October 31, 2023 | 61.31% |
| September 30, 2023 | 53.16% |
| August 31, 2023 | 45.13% |
| July 31, 2023 | 41.44% |
| June 30, 2023 | 41.44% |
| May 31, 2023 | 41.44% |
| April 30, 2023 | 41.44% |
| March 31, 2023 | 41.44% |
| February 28, 2023 | 41.44% |
| January 31, 2023 | 41.44% |
| December 31, 2022 | 41.44% |
| November 30, 2022 | 41.44% |
| October 31, 2022 | 41.44% |
| September 30, 2022 | 41.44% |
| August 31, 2022 | 41.44% |
| July 31, 2022 | 41.44% |
| June 30, 2022 | 41.44% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Abbott Laboratories | 39.63% |
| DexCom, Inc. | 66.32% |
| Boston Scientific Corp. | 60.58% |
| PROCEPT BioRobotics Corp. | -- |
| Globus Medical, Inc. | 47.91% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -23.80 |
| Beta (5Y) | 1.104 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.27% |
| Historical Sharpe Ratio (5Y) | -0.3225 |
| Historical Sortino (5Y) | -0.5321 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.60% |